Targeting the brain’s immune cells may help prevent or treat Alzheimer’s disease

A gene mutation linked to Alzheimer’s disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine. The team also found that blocking the pathway—with a drug that’s currently being tested in cancer clinical trials—protects against many features of the condition […]

Continue Reading

New research shows effectiveness of ointment that kills antibiotic-resistant bacteria

Research from the University of Cincinnati College of Medicine shows that use of a topical drug called AB569, a combination of acidified nitrite and EDTA (or ethylenediaminetetraacetic acid) promotes killing of antibiotic-resistant bacteria while enhancing the healing of wounds in a variety of burn injuries. The study was published in the journal Infection and Immunity. […]

Continue Reading

Magnetic resonance imaging and artificial intelligence can detect early signs of tumor cell death after novel therapy

In a recent study published in Nature Biomedical Engineering, a team led by researchers at Massachusetts General Hospital (MGH) has demonstrated that magnetic resonance imaging (MRI) and artificial intelligence (AI) can be used to detect early signs of tumor cell death in response to a novel virus-based cancer therapy. Recently, a promising therapeutic virus that […]

Continue Reading

Compound shows promise for minimizing erratic movements in Parkinson’s patients

A new study from Texas Biomedical Research Institute (Texas Biomed) and collaborators has identified a promising drug candidate to minimize uncontrolled, erratic muscle movements, called dyskinesia, associated with Parkinson’s disease. The small molecule, called PD13R, reduced dyskinesia by more than 85% in the marmoset animal model of Parkinson’s disease. Additionally, the animals got much better […]

Continue Reading